每日半剂量利奈唑胺治疗难治性耐多药结核病。 - Suppr

Suppr

超能文献

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.

作者信息

Nam Hae-Seong, Koh Won-Jung, Kwon O Jung, Cho Sang-Nae, Shim Tae Sun

出版信息

Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.

DOI:10.1016/j.ijantimicag.2008.06.014

PMID:18789655

Abstract

摘要

相似文献

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.

Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.

J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.

J Antimicrob Chemother. 2006 Sep;58(3):701-4. doi: 10.1093/jac/dkl298. Epub 2006 Jul 19.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Aug;64(2):388-91. doi: 10.1093/jac/dkp171. Epub 2009 May 25.

Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.

Pediatr Infect Dis J. 2009 Aug;28(8):748-50. doi: 10.1097/INF.0b013e31819bc491.

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

Int J Tuberc Lung Dis. 2008 Mar;12(3):345-6.

In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates.

Int J Antimicrob Agents. 2009 Feb;33(2):190-1. doi: 10.1016/j.ijantimicag.2008.08.007. Epub 2008 Oct 21.

Linezolid in the treatment of MDR-TB: a retrospective clinical study.

Int J Tuberc Lung Dis. 2012;16(3):358-63. doi: 10.5588/ijtld.11.0493.

引用本文的文献

Clinical effectiveness and reliability of linezolid in the treatment of pulmonary tuberculosis complicated with severe pneumonia: a meta-analysis.

Am J Transl Res. 2022 Nov 15;14(11):7622-7631. eCollection 2022.

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.

J Infect Dis. 2021 Jun 4;223(11):1855-1864. doi: 10.1093/infdis/jiaa016.

Linezolid for drug-resistant pulmonary tuberculosis.

Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2.

Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.

Ann Clin Microbiol Antimicrob. 2016 Jun 22;15(1):41. doi: 10.1186/s12941-016-0156-y.

Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.

J Thorac Dis. 2015 Apr;7(4):603-15. doi: 10.3978/j.issn.2072-1439.2015.03.10.

Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case review.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e50-2. doi: 10.1155/2013/535616.

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.

Antimicrob Agents Chemother. 2013 Sep;57(9):4097-104. doi: 10.1128/AAC.00120-13. Epub 2013 Jun 17.

World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?

J Infect Dis. 2013 May 1;207(9):1352-8. doi: 10.1093/infdis/jis460. Epub 2012 Jul 17.

Antituberculosis therapy for 2012 and beyond.

Expert Opin Pharmacother. 2012 Mar;13(4):511-26. doi: 10.1517/14656566.2012.657176. Epub 2012 Feb 15.

Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems?

Infect Drug Resist. 2012;5:1-8. doi: 10.2147/IDR.S27604. Epub 2012 Jan 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验